Vycor Medical (VYCO) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 26.90% |
| Sep 30, 2025 | 16.60% |
| Jun 30, 2025 | 17.68% |
| Mar 31, 2025 | 38.59% |
| Dec 31, 2024 | 15.26% |
| Sep 30, 2024 | 26.67% |
| Jun 30, 2024 | 16.26% |
| Mar 31, 2024 | 43.31% |
| Dec 31, 2023 | 32.72% |
| Sep 30, 2023 | 28.11% |
| Jun 30, 2023 | 17.48% |
| Mar 31, 2023 | 16.06% |
| Dec 31, 2022 | 24.15% |
| Sep 30, 2022 | 21.51% |
| Jun 30, 2022 | 26.80% |
| Mar 31, 2022 | 29.31% |
| Dec 31, 2021 | 18.96% |
| Sep 30, 2021 | 22.45% |
| Jun 30, 2021 | 15.78% |
| Mar 31, 2021 | 16.67% |
| Dec 31, 2020 | 15.88% |
| Sep 30, 2020 | 16.52% |
| Jun 30, 2020 | 15.33% |
| Mar 31, 2020 | 24.76% |
| Sep 30, 2019 | 17.66% |
| Jun 30, 2019 | 28.60% |
| Mar 31, 2019 | 30.34% |
| Dec 31, 2018 | 4.59% |
| Sep 30, 2018 | 22.81% |
| Jun 30, 2018 | 7.82% |
| Mar 31, 2018 | 12.11% |
| Dec 31, 2017 | 7.24% |
| Sep 30, 2017 | 17.26% |
| Jun 30, 2017 | 13.78% |
| Mar 31, 2017 | 16.98% |
| Dec 31, 2016 | 10.09% |
| Sep 30, 2016 | 22.26% |
| Jun 30, 2016 | 30.56% |
| Mar 31, 2016 | 10.80% |
| Dec 31, 2015 | 13.40% |
| Sep 30, 2015 | -7.93% |
| Jun 30, 2015 | -2.32% |